Funding Rounds
Mablink Bioscience

Mablink Bioscience Series A (2022, $30M)

Mablink Bioscience

Biotechnology company developing advanced cancer treatments.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $30.14M

Raised Date: 2022-01-01

Investors